Medicilon establishes a biopharmaceutical technology company in Shanghai.

Qichacha APP shows that MediSci Puxu Biopharmaceutical Technology Co., Ltd. was recently established, with Chen Yonghang as the legal representative and a registered capital of 10 million yuan. Its business scope includes: medical research and experimental development; import and export of goods, etc. Qichacha equity penetration shows that the company is indirectly wholly owned by MediSci.